
Servier and BC Partners enter exclusive negotiations for the sale of Biogaran
BC Partners is excited to support Biogaran in building a French-headquartered, industry-leading supplier of high-quality generic medication. Leveraging its deep…
Discover our latest insights and keep up to date with BC Partners’ news.
BC Partners is excited to support Biogaran in building a French-headquartered, industry-leading supplier of high-quality generic medication. Leveraging its deep…
Under BC Partners’ ownership, NAVEX has grown into the global leader in governance, risk and compliance software BC Partners to…
Launched in partnership with BMO Sponsor Finance, using its Great Lakes trade name for the fund High rate of investor…
OfficeMax Incorporated (NYSE:OMX) and Office Depot, Inc. (NYSE:ODP) announced on 20 February 2013 the signing of a definitive merger agreement…
The Aenova Group, one of the leading companies in the global pharmaceutical and healthcare industry, is in the process of…
Hamburg/Munich, August 6, 2012 – Funds advised by BC Partners (“BC Partners”) are acquiring the Aenova Group, one of the…
BC Partners, a leading international private equity firm, and global alternative asset manager The Carlyle Group (NASDAQ: CG) today announced…
Brachem Acquisition S.C.A., the major shareholder of Brenntag AG, announced today that it placed 6.9 million shares of Brenntag AG…
Brachem Acquisition S.C.A. Luxembourg announced today that it has successfully sold 7.0 million shares of its remaining share in Brenntag…
February 21, 2012 – BC Partners announces the final closing of BC European Capital IX (“BCEC IX” or “the Fund”)…
BC Partners today announces that Brave B Lux SA, a company owned by funds it advises, has signed an agreement…
July 21, 2011 – BC Partners, a leading international private equity firm, today announces that it has signed an agreement…